| 6501 |
Apheresis |
Allogeneic |
Non-Hodgkin Lymphoma |
Hematology |
2018 |
Standard Therapy |
Poland |
54 |
| 6502 |
Apheresis |
Autologous |
Non-Hodgkin Lymphoma |
Hematology |
2018 |
Standard Therapy |
Germany |
72 |
| 6503 |
Apheresis |
Autologous |
Non-Hodgkin Lymphoma |
Hematology |
2018 |
Standard Therapy |
Germany |
54 |
| 6504 |
Apheresis |
Autologous |
Non-Hodgkin Lymphoma |
Hematology |
2018 |
Standard Therapy |
Germany |
58 |
| 6505 |
Apheresis |
Autologous |
Non-Hodgkin Lymphoma |
Hematology |
2018 |
Standard Therapy |
Germany |
63 |
| 6506 |
Apheresis |
Autologous |
Non-Hodgkin Lymphoma |
Hematology |
2018 |
Standard Therapy |
Germany |
48 |
| 6507 |
Apheresis |
Autologous |
Non-Hodgkin Lymphoma |
Hematology |
2018 |
Standard Therapy |
Germany |
62 |
| 6508 |
Apheresis |
Allogeneic |
Non-Hodgkin Lymphoma; Diffuse Large B-Cell Lymphoma |
Hematology |
2018 |
Standard Therapy |
Poland |
62 |
| 6509 |
Apheresis |
Autologous |
Non-Hodgkin-Lymphoma-Relapse |
Hematology |
2018 |
Standard Therapy |
Germany |
51 |
| 6510 |
Apheresis |
Allogeneic |
Other Malignancy |
Hematology |
2018 |
Standard Therapy |
Poland |
59 |
| 6511 |
Apheresis |
Allogeneic |
Other Myelodysplastic Syndromes |
Hematology |
2018 |
Standard Therapy |
Poland |
67 |
| 6512 |
Apheresis |
Allogeneic |
Other Myelofibrosis |
Hematology |
2018 |
Standard Therapy |
Poland |
57 |
| 6513 |
Apheresis |
Allogeneic |
Peripheral T-Cell Lymphoma |
Hematology |
2018 |
Standard Therapy |
Poland |
50 |
| 6514 |
Apheresis |
Allogeneic |
Plasma Cell Disorder |
Hematology |
2018 |
Standard Therapy |
Poland |
64 |
| 6515 |
Apheresis |
Allogeneic |
Plasma Cell Disorder |
Hematology |
2018 |
Standard Therapy |
Poland |
57 |
| 6516 |
Apheresis |
Autologous |
Plasma Cell Leukemia |
Hematology |
2018 |
Standard Therapy |
Germany |
52 |
| 6517 |
Apheresis |
Allogeneic |
Post-Essential Thrombocythemia-Myelofibrosis |
Hematology |
2018 |
Standard Therapy |
Germany |
53 |
| 6518 |
Apheresis |
Autologous |
Primary Central Nervous System Lymphoma |
Hematology |
2018 |
Standard Therapy |
Germany |
67 |
| 6519 |
Apheresis |
Autologous |
Primary Central Nervous System Lymphoma |
Hematology |
2018 |
Standard Therapy |
Germany |
69 |
| 6520 |
Apheresis |
Autologous |
Primary Central Nervous System Lymphoma |
Hematology |
2018 |
Standard Therapy |
Germany |
66 |
| 6521 |
Apheresis |
Autologous |
Primary Central Nervous System Lymphoma Relapse |
Hematology |
2018 |
Standard Therapy |
Germany |
63 |
| 6522 |
Apheresis |
Allogeneic |
Primary Immunodeficiency |
Hematology |
2018 |
Standard Therapy |
Poland |
3 |
| 6523 |
Apheresis |
Allogeneic |
Primary Myelofibrosis; Secondary Acute Myelogenous Leukemia |
Hematology |
2018 |
Standard Therapy |
Poland |
53 |
| 6524 |
Apheresis |
Allogeneic |
Prolymphocytic Leukemia |
Hematology |
2018 |
Standard Therapy |
Poland |
62 |
| 6525 |
Apheresis |
Autologous |
Refractory Diffuse Large B-Cell Lymphoma |
Hematology |
2018 |
Standard Therapy |
Germany |
36 |
| 6526 |
Apheresis |
Allogeneic |
Refractory Diffuse Large B-Cell Lymphoma |
Hematology |
2018 |
Standard Therapy |
Germany |
50 |
| 6527 |
Apheresis |
Allogeneic |
Secondary Acute Myeloid Leukemia |
Hematology |
2018 |
Standard Therapy |
Poland |
58 |
| 6528 |
Apheresis |
Allogeneic |
Secondary Acute Myeloid Leukemia |
Hematology |
2018 |
Standard Therapy |
Germany |
68 |
| 6529 |
Apheresis |
Allogeneic |
Secondary Acute Myeloid Leukemia At Primary Myelofibrosis |
Hematology |
2018 |
Standard Therapy |
Germany |
56 |
| 6530 |
Apheresis |
Allogeneic |
Severe Aplastic Anemia |
Hematology |
2018 |
Standard Therapy |
Poland |
18 |
| 6531 |
Apheresis |
Allogeneic |
Severe Aplastic Anemia |
Hematology |
2018 |
Standard Therapy |
Poland |
74 |
| 6532 |
Apheresis |
Allogeneic |
Severe Aplastic Anemia |
Hematology |
2018 |
Standard Therapy |
Poland |
24 |
| 6533 |
Apheresis |
Allogeneic |
Severe Aplastic Anemia |
Hematology |
2018 |
Standard Therapy |
Poland |
70 |
| 6534 |
Apheresis |
Allogeneic |
Severe Aplastic Anemia |
Hematology |
2018 |
Standard Therapy |
Poland |
6 |
| 6535 |
Apheresis |
Allogeneic |
Severe Aplastic Anemia |
Hematology |
2018 |
Standard Therapy |
Poland |
13 |
| 6536 |
Apheresis |
Allogeneic |
Severe Combined Immunodeficiency |
Hematology |
2018 |
Standard Therapy |
Poland |
2 |
| 6537 |
Apheresis |
Allogeneic |
T-Cell Acute Lymphoblastic Leukemia |
Hematology |
2018 |
Standard Therapy |
Poland |
7 |
| 6538 |
Apheresis |
Allogeneic |
T-Cell Acute Lymphoblastic Leukemia |
Hematology |
2018 |
Standard Therapy |
Poland |
13 |
| 6539 |
Apheresis |
Allogeneic |
T-Cell Acute Lymphoblastic Leukemia |
Hematology |
2018 |
Standard Therapy |
Poland |
45 |
| 6540 |
Apheresis |
Allogeneic |
T-Cell Acute Lymphoblastic Leukemia |
Hematology |
2018 |
Standard Therapy |
Poland |
40 |
| 6541 |
Apheresis |
Autologous |
T-Cell Non-Hodgkin Lymphoma |
Hematology |
2018 |
Standard Therapy |
Germany |
67 |
| 6542 |
Apheresis |
Autologous |
T-Cell-Lymphoma |
Hematology |
2018 |
Standard Therapy |
Germany |
67 |
| 6543 |
Apheresis |
Allogeneic |
T-Cell-Lymphoma |
Hematology |
2018 |
Standard Therapy |
Germany |
23 |
| 6544 |
Apheresis |
Allogeneic |
Thalassemia Major |
Hematology |
2018 |
Standard Therapy |
Poland |
5 |
| 6545 |
Apheresis |
Allogeneic |
Therapy-Related Myelodysplastic Syndromes |
Hematology |
2018 |
Standard Therapy |
Poland |
65 |
| 6546 |
Adipose Tissue |
Autologous |
Condition After Injury Of The Left Knee Joint |
Orthopedy |
2018 |
Experimental Therapy |
Poland |
33 |
| 6547 |
Adipose Tissue |
Autologous |
Coxarthrosis |
Orthopedy |
2018 |
Experimental Therapy |
Poland |
53 |
| 6548 |
Adipose Tissue |
Autologous |
Cutis Laxa |
Dermatology |
2018 |
Clinical Trial |
Poland |
no data |
| 6549 |
Adipose Tissue |
Autologous |
Cutis Laxa |
Dermatology |
2018 |
Clinical Trial |
Poland |
no data |
| 6550 |
Adipose Tissue |
Autologous |
Cutis Laxa |
Dermatology |
2018 |
Clinical Trial |
Poland |
no data |
| 6551 |
Adipose Tissue |
Autologous |
Cutis Laxa |
Dermatology |
2018 |
Clinical Trial |
Poland |
no data |
| 6552 |
Adipose Tissue |
Autologous |
Cutis Laxa |
Dermatology |
2018 |
Clinical Trial |
Poland |
no data |
| 6553 |
Adipose Tissue |
Autologous |
Cutis Laxa |
Dermatology |
2018 |
Clinical Trial |
Poland |
no data |
| 6554 |
Adipose Tissue |
Autologous |
Cutis Laxa |
Dermatology |
2018 |
Clinical Trial |
Poland |
no data |
| 6555 |
Adipose Tissue |
Autologous |
Cutis Laxa |
Dermatology |
2018 |
Clinical Trial |
Poland |
no data |
| 6556 |
Adipose Tissue |
Autologous |
Gonarthrosis |
Orthopedy |
2018 |
Experimental Therapy |
Poland |
69 |
| 6557 |
Adipose Tissue |
Autologous |
Gonarthrosis |
Orthopedy |
2018 |
Experimental Therapy |
Poland |
42 |
| 6558 |
Adipose Tissue |
Autologous |
Scar |
Dermatology |
2018 |
Clinical Trial |
Poland |
no data |
| 6559 |
Adipose Tissue |
Autologous |
Scar |
Dermatology |
2018 |
Clinical Trial |
Poland |
no data |
| 6560 |
Adipose Tissue |
Autologous |
Scar |
Dermatology |
2018 |
Clinical Trial |
Poland |
no data |
| 6561 |
Adipose Tissue |
Autologous |
Scar |
Dermatology |
2018 |
Clinical Trial |
Poland |
no data |
| 6562 |
Adipose Tissue |
Autologous |
Scar |
Dermatology |
2018 |
Clinical Trial |
Poland |
no data |
| 6563 |
Adipose Tissue |
Autologous |
Scar |
Dermatology |
2018 |
Clinical Trial |
Poland |
no data |
| 6564 |
Adipose Tissue |
Autologous |
Scar |
Dermatology |
2018 |
Clinical Trial |
Poland |
no data |
| 6565 |
Adipose Tissue |
Autologous |
Scar |
Dermatology |
2018 |
Clinical Trial |
Poland |
no data |
| 6566 |
Adipose Tissue |
Autologous |
Scar |
Dermatology |
2018 |
Clinical Trial |
Poland |
no data |
| 6567 |
Adipose Tissue |
Autologous |
Scar |
Dermatology |
2018 |
Clinical Trial |
Poland |
no data |
| 6568 |
Adipose Tissue |
Autologous |
Scar |
Dermatology |
2018 |
Clinical Trial |
Poland |
no data |
| 6569 |
Cord Tissue |
Allogeneic – Unrelated |
Limb-Girdle Muscular Dystrophy |
Neurology |
2017 |
Experimental Therapy |
Poland |
44,2 |
| 6570 |
Cord Tissue |
Allogeneic – Unrelated |
Limb-Girdle Muscular Dystrophy |
Neurology |
2017 |
Experimental Therapy |
Poland |
25,8 |
| 6571 |
Cord Tissue |
Allogeneic – Unrelated |
Limb-Girdle Muscular Dystrophy |
Neurology |
2017 |
Experimental Therapy |
Poland |
38,5 |
| 6572 |
Cord Tissue |
Allogeneic – Unrelated |
Limb-Girdle Muscular Dystrophy |
Neurology |
2017 |
Experimental Therapy |
Poland |
26,1 |
| 6573 |
Cord Tissue |
Allogeneic – Unrelated |
Limb-Girdle Muscular Dystrophy |
Neurology |
2017 |
Experimental Therapy |
Poland |
37,11 |
| 6574 |
Cord Tissue |
Allogeneic – Unrelated |
Limb-Girdle Muscular Dystrophy |
Neurology |
2017 |
Experimental Therapy |
Poland |
62,5 |
| 6575 |
Cord Tissue |
Allogeneic – Unrelated |
Limb-Girdle Muscular Dystrophy |
Neurology |
2017 |
Experimental Therapy |
Poland |
35,4 |
| 6576 |
Cord Tissue |
Allogeneic – Unrelated |
Limb-Girdle Muscular Dystrophy |
Neurology |
2017 |
Experimental Therapy |
Poland |
31,3 |
| 6577 |
Cord Tissue |
Allogeneic – Unrelated |
Acute Graft Versus Host Disease |
Hematology |
2017 |
Experimental Therapy |
Poland |
13 |
| 6578 |
Cord Tissue |
Allogeneic – Unrelated |
Acute Graft Versus Host Disease |
Hematology |
2017 |
Experimental Therapy |
Poland |
11,1 |
| 6579 |
Cord Tissue |
Allogeneic – Unrelated |
Acute Graft Versus Host Disease |
Hematology |
2017 |
Experimental Therapy |
Poland |
2,4 |
| 6580 |
Cord Tissue |
Allogeneic – Unrelated |
Acute Graft Versus Host Disease |
Hematology |
2017 |
Experimental Therapy |
Poland |
8,1 |
| 6581 |
Cord Tissue |
Allogeneic – Unrelated |
Acute Graft Versus Host Disease |
Hematology |
2017 |
Experimental Therapy |
Poland |
7,6 |
| 6582 |
Cord Tissue |
Allogeneic – Unrelated |
Age-Related Macular Degeneration |
Ophthalmology |
2017 |
Experimental Therapy |
Poland |
33,4 |
| 6583 |
Cord Tissue |
Allogeneic – Unrelated |
Amyotrophic Lateral Sclerosis |
Neurology |
2017 |
Experimental Therapy |
Poland |
67,11 |
| 6584 |
Cord Tissue |
Allogeneic – Unrelated |
Amyotrophic Lateral Sclerosis |
Neurology |
2017 |
Experimental Therapy |
Poland |
37,9 |
| 6585 |
Cord Tissue |
Allogeneic – Unrelated |
Amyotrophic Lateral Sclerosis |
Neurology |
2017 |
Experimental Therapy |
Poland |
71,7 |
| 6586 |
Cord Tissue |
Allogeneic – Unrelated |
Amyotrophic Lateral Sclerosis |
Neurology |
2017 |
Experimental Therapy |
Poland |
no data |
| 6587 |
Cord Tissue |
Allogeneic – Unrelated |
Amyotrophic Lateral Sclerosis |
Neurology |
2017 |
Experimental Therapy |
Poland |
47,6 |
| 6588 |
Cord Tissue |
Allogeneic – Unrelated |
Amyotrophic Lateral Sclerosis |
Neurology |
2017 |
Experimental Therapy |
Poland |
56,7 |
| 6589 |
Cord Tissue |
Allogeneic – Unrelated |
Amyotrophic Lateral Sclerosis |
Neurology |
2017 |
Experimental Therapy |
Poland |
48,11 |
| 6590 |
Cord Tissue |
Allogeneic – Unrelated |
Amyotrophic Lateral Sclerosis |
Neurology |
2017 |
Experimental Therapy |
Poland |
46,3 |
| 6591 |
Cord Tissue |
Allogeneic – Unrelated |
Amyotrophic Lateral Sclerosis |
Neurology |
2017 |
Experimental Therapy |
Poland |
45,9 |
| 6592 |
Cord Tissue |
Allogeneic – Unrelated |
Amyotrophic Lateral Sclerosis |
Neurology |
2017 |
Experimental Therapy |
Poland |
75,9 |
| 6593 |
Cord Tissue |
Allogeneic – Unrelated |
Amyotrophic Lateral Sclerosis |
Neurology |
2017 |
Experimental Therapy |
Poland |
51,3 |
| 6594 |
Cord Tissue |
Allogeneic – Unrelated |
Amyotrophic Lateral Sclerosis |
Neurology |
2017 |
Experimental Therapy |
Poland |
59,8 |
| 6595 |
Cord Tissue |
Allogeneic – Unrelated |
Amyotrophic Lateral Sclerosis |
Neurology |
2017 |
Experimental Therapy |
Poland |
64,9 |
| 6596 |
Cord Tissue |
Allogeneic – Unrelated |
Amyotrophic Lateral Sclerosis |
Neurology |
2017 |
Experimental Therapy |
Poland |
56,7 |
| 6597 |
Cord Tissue |
Allogeneic – Unrelated |
Amyotrophic Lateral Sclerosis |
Neurology |
2017 |
Experimental Therapy |
Poland |
40,11 |
| 6598 |
Cord Tissue |
Allogeneic – Unrelated |
Amyotrophic Lateral Sclerosis |
Neurology |
2017 |
Experimental Therapy |
Poland |
69,1 |
| 6599 |
Cord Tissue |
Allogeneic – Unrelated |
Amyotrophic Lateral Sclerosis |
Neurology |
2017 |
Experimental Therapy |
Poland |
52 |
| 6600 |
Cord Tissue |
Allogeneic – Unrelated |
Amyotrophic Lateral Sclerosis |
Neurology |
2017 |
Experimental Therapy |
Poland |
35,1 |